Citation Impact
Citing Papers
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
2005
Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
2006
Systematic Review and Cumulative Analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Cystectomy
2015
The neural control of micturition
2008 Standout
Phosphodiesterase Type 5 Inhibitors: State of the Therapeutic Class
2007
Antidepressants and sexual dysfunction
2006
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Characterization and Functional Role of Androgen-Dependent PDE5 Activity in the Bladder
2006
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
2008
Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia
2009
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Chronic sildenafil in men with diabetes and erectile dysfunction
2007
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Disparities in bladder cancer
2011
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid–hyaluronidase and BTA‐Stat tests
2002
Urine Markers for Bladder Cancer Surveillance: A Systematic Review
2005
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms
2008
The effect of sildenafil citrate on bladder outlet obstruction: a mouse model
2008
Results of Double-Blind Placebo-Controlled Crossover Study of Sildenafil Citrate (Viagra) in Women Suffering from Obstructed Voiding or Retention Associated with the Primary Disorder of Sphincter Relaxation (Fowler’s Syndrome)
2006
Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States)
2006
A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
2012
Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7)
2003
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Prognostic factors and outcome in patients with T1 high‐grade bladder cancer: can we identify patients for early cystectomy?
2011
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach
2006
Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia
2006
Prevention and Treatment of the Metabolic Syndrome
2004
Urinary Biomarkers for Diagnosis of Bladder Cancer
2015
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
2010
Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
2007
Works of G. Boustead being referenced
Time trends in case selection, stage and prostate‐specific antigen recurrence after radical prostatectomy: a multicentre audit
2004
Oral sildenafil (Viagra™) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospital.
2002
Sildenafil influences lower urinary tract symptoms
2002
The Early Detection and Diagnosis of Bladder Cancer: A Critical Review of the Options
2001
Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta‐analysis of randomized controlled trials
2007
The measurement of psychological distress in men being investigated for the presence of prostate cancer
2008
A study comparing various noninvasive methods of detecting bladder cancer in urine
2002
Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction
2001
Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre
2013